Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 20:2020:6598434.
doi: 10.1155/2020/6598434. eCollection 2020.

Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential

Affiliations
Review

Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential

Lyca R da Fonseca et al. ScientificWorldJournal. .

Abstract

Herbal medicines containing Passiflora species have been widely used to treat anxiety since ancient times. The species Passiflora incarnata L. is included in many Pharmacopoeias, and it is the most used species in food, cosmetic, and pharmaceutical industries. However, there are around 600 species of the genus Passiflora and probably other species that can be used safely. Thus, this article was based on a search into the uses of the main species of the genus Passiflora with anxiolytic activity and its main secondary metabolites and some pharmacological studies, patents, and registered products containing Passiflora. Furthermore, the Brazilian Regulatory Health Agency Datavisa, Medicines and Healthcare Products Regulatory Agency of the United Kingdom, and the European Medicines Agency websites were consulted. The results showed that Passiflora species have health benefits but clinical trials are still scarce. The complexity of Passiflora extracts creates challenges for the development of herbal medicines. P. incarnata is the most studied species of the genus and the most used in natural anxiolytic herbal medicine formulations. However, there are hundreds of Passiflora species potentially useful for medicinal and nutraceutical purposes that are still little explored.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Flavonoids of Passiflora incarnata.
Figure 2
Figure 2
Alkaloids of Passiflora incarnata.
Figure 3
Figure 3
Valid and canceled/expired registrations of Passiflora-containing medicines registered in Brazil (ANVISA).
Figure 4
Figure 4
Distribution of Passiflora species in ANVISA registered products containing Passiflora sp.
Figure 5
Figure 5
Distribution of preparations containing Passiflora incarnata registered in Europe Union, according to the European Medicines Agency [21].

References

    1. Carlini E. A. Plants and the central nervous system. Pharmacology Biochemistry and Behavior. 2003;75:501–512. doi: 10.1016/s0091-3057(03)00112-6. - DOI - PubMed
    1. Dhawan K., Kumar S., Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus: a comment on medicinal plants’ standardization. Journal of Alternative and Complementary Medicine. 2002;8(3):283–291. doi: 10.1089/10755530260127970. - DOI - PubMed
    1. Wakdikar S. Global health care challenge: Indian experiences and new prescriptions. Electronic Journal of Biotechnoly. 2004;7:214–220. doi: 10.2225/vol7-issue3-fulltext-5. - DOI
    1. Germany, Federal Law Gazette [BGBl] Medicinal products act, part I. 2005;12:p. 3394. Updated by Federal Law Gazette I, Law of October 19, 2012, p. 2192. http://www.gesetze-im-internet.de/englisch_amg/medicinal_products_act.pdf.
    1. E Union. Directive 2001/83/EC. Official Journal of the European Union; 2001. http://www.wipo.int/wipolex/en/text.jsp?file_id=291864.

LinkOut - more resources